SS-31 (Elamipretide): Targeting the Inner Mitochondrial Membrane in Research
Mitochondrial dysfunction is a central variable in numerous areas of biological research, from cellular bioenergetics to oxidative stress modeling. Among the compounds developed to target mitochondrial function directly, SS-31 – also known as Elamipretide or – stands out for its unique mechanism: selective binding to cardiolipin on the inner mitochondrial membrane. This targeted interaction distinguishes SS-31 from other mitochondria-associated peptides and has made it a widely studied tool in mitochondrial biology research.
This article reviews the Szeto-Schiller peptide family, the cardiolipin binding mechanism, SS-31’s effects on mitochondrial structure and reactive oxygen species (ROS) in model systems, and how it differs mechanistically from other mitochondrial peptides.
The Szeto-Schiller Peptide Family
SS-31 belongs to the Szeto-Schiller (SS) peptide family, a series of small, cell-permeable tetrapeptides developed by Hazel Szeto and Peter Bhatt Schiller. The SS peptides share a common structural motif: alternating aromatic and basic amino acid residues that confer both mitochondrial targeting and membrane interaction properties (Szeto, 2014).
The specific sequence of SS-31 is D-Arg-Dmt-Lys-Phe-NH2, where Dmt is 2′,6′-dimethyltyrosine. Key structural features include:
- Net positive charge (+3): The cationic nature facilitates electrostatic attraction to the negatively charged inner mitochondrial membrane
- Aromatic residues: The Dmt and Phe residues enable hydrophobic interactions with lipid bilayer components
- Small size: At only four amino acids, SS-31 readily penetrates cell membranes and concentrates in mitochondria without requiring active transport
- Mitochondrial concentration: SS peptides accumulate in mitochondria at concentrations estimated to be 1,000-5,000 fold higher than extracellular levels (Zhao et al., 2004)
This exceptional mitochondrial concentration is not driven solely by the mitochondrial membrane potential (as with lipophilic cations like TPP+), but rather by the specific affinity of SS-31 for cardiolipin – a feature that has significant implications for its mechanism of action.
Cardiolipin Binding: The Core Mechanism
The defining mechanistic feature of SS-31 is its selective interaction with cardiolipin, a phospholipid found almost exclusively on the inner mitochondrial membrane. Cardiolipin plays essential roles in mitochondrial function:
- Electron transport chain (ETC) organization: Cardiolipin is required for the proper assembly and function of ETC complexes I, III, IV, and V
- Cristae architecture: Cardiolipin stabilizes the curved membrane structures (cristae) that maximize the surface area for oxidative phosphorylation
- Cytochrome c interaction: Cardiolipin anchors cytochrome c to the inner membrane, maintaining its electron carrier function and preventing its release into the cytosol
Birk et al. (2013) demonstrated through biophysical studies that SS-31 binds to cardiolipin through electrostatic and hydrophobic interactions. The positively charged Arg and Lys residues interact with cardiolipin’s anionic phosphate headgroups, while the aromatic Dmt and Phe residues insert into the hydrophobic acyl chain region. This binding interaction does not displace cardiolipin from its functional sites but rather modulates its interaction with the proteins embedded in the inner membrane (Birk et al., 2013).
Critically, this means SS-31’s mechanism is fundamentally structural – it stabilizes cardiolipin-protein interactions rather than acting as an enzyme inhibitor, receptor agonist, or scavenger molecule.
Mitochondrial Cristae Stabilization Research
One of the most actively studied consequences of SS-31’s cardiolipin binding is its effect on mitochondrial cristae morphology. In cell culture models and in vitro systems, disruption of cardiolipin organization leads to cristae remodeling – the normally tight, lamellar cristae structures become disorganized, widened, or vesiculated. This structural disruption impairs ETC efficiency and ATP production.
Research has shown that SS-31’s cardiolipin interaction can stabilize cristae architecture in model systems subjected to various stressors. Siegel et al. (2021) reported that in preclinical models, SS-31 preserved cristae ultrastructure under conditions that normally produce cristae disorganization, as assessed by electron microscopy. The preserved cristae structure correlated with:
- Maintained ETC supercomplex assembly: The respiratory chain complexes remained organized in functional supercomplexes
- Preserved ATP synthesis capacity: Oxidative phosphorylation efficiency was maintained in SS-31-exposed models
- Stabilized cytochrome c interaction: Cytochrome c remained properly anchored to the inner membrane, reducing its release to the cytosol (Birk et al., 2013)
ROS Reduction in Cell Culture Models
A consistently observed effect of SS-31 in cell culture research is reduction of mitochondrial reactive oxygen species (ROS) production. However, the mechanism of ROS reduction is important to understand – SS-31 is not a conventional antioxidant in the scavenger sense.
Rather than directly neutralizing ROS molecules (as a compound like N-acetylcysteine or vitamin E would), SS-31 reduces ROS production at the source by optimizing electron transport chain function. When ETC complexes are disorganized due to cardiolipin disruption, electron leak increases, and more electrons are transferred to molecular oxygen to form superoxide. By stabilizing cardiolipin-ETC interactions, SS-31 reduces this electron leak (Szeto, 2014).
Zhao et al. (2004) documented this ROS-reducing effect in early characterization studies, demonstrating that SS peptides reduced mitochondrial ROS in cell culture systems exposed to oxidative challenges. The magnitude of ROS reduction correlated with mitochondrial membrane potential preservation and cell viability maintenance in these model systems.
This “upstream” approach to ROS management – preventing excess production rather than scavenging after production – is a conceptually distinct strategy that has driven significant research interest in SS-31.
Distinction from Other Mitochondrial Peptides
Researchers working in mitochondrial biology encounter several peptide compounds associated with mitochondrial function. It is important to distinguish SS-31’s mechanism from these other molecules:
MOTS-c
MOTS-c is a mitochondrial-derived peptide (MDP) encoded within the mitochondrial genome’s 12S rRNA gene. Unlike SS-31, MOTS-c is an endogenous signaling molecule that exerts its effects primarily through AMPK pathway activation and metabolic regulation in the cytoplasm and nucleus. MOTS-c does not bind cardiolipin and does not directly target the inner mitochondrial membrane. Its mechanism involves retrograde signaling from mitochondria to the nucleus, influencing gene expression related to metabolic adaptation.
Humanin
Humanin is another MDP that functions as a secreted signaling peptide, interacting with extracellular receptors (including FPRL1 and CNTFR/WSX-1/gp130 complex). Like MOTS-c, Humanin operates through receptor-mediated signaling rather than direct mitochondrial membrane interaction.
SS-31’s Unique Position
SS-31 is unique among these compounds in that it:
- Is a synthetic, exogenous peptide (not encoded by the mitochondrial genome)
- Acts directly at the inner mitochondrial membrane through cardiolipin binding
- Modulates mitochondrial structure and bioenergetics at the organelle level
- Does not rely on cell surface receptors or nuclear signaling for its primary mechanism
Laboratory Protocol Considerations
For researchers incorporating SS-31 into their experimental protocols:
Storage and Reconstitution
- Lyophilized storage: Maintain at -20°C or below, protected from light. The Dmt residue may be susceptible to oxidation under improper storage conditions
- Reconstitution: Dissolve in sterile water, saline, or appropriate cell culture-compatible buffer. SS-31 is water-soluble due to its cationic character
- Working solutions: Prepare fresh working dilutions from concentrated stocks. Store reconstituted stocks at 2-8°C for short-term use
Experimental Design Considerations
- Concentration range: Published cell culture studies typically employ nanomolar to low micromolar concentrations. Concentration-response experiments are recommended for each new model system
- Pre-incubation time: SS-31 concentrates rapidly in mitochondria (within minutes in cell culture), but equilibrium distribution may take longer depending on cell type
- Assay endpoints: Mitochondrial membrane potential (JC-1, TMRM), ROS production (MitoSOX), oxygen consumption rate (Seahorse), ATP levels, and electron microscopy for cristae morphology are common readouts
- Controls: Scrambled sequence peptides or SS-20 (a related SS peptide with reduced cardiolipin affinity) serve as appropriate negative controls
Explore the full selection of research-grade peptides at Aureum Peptides, including SS-31 for mitochondrial biology research.
Summary
SS-31 (Elamipretide) represents a mechanistically distinct approach to mitochondrial research – targeting cardiolipin on the inner mitochondrial membrane to stabilize cristae structure, optimize electron transport chain function, and reduce ROS production at its source. The foundational work by Zhao et al. (2004), Birk et al. (2013), Szeto (2014), and Siegel et al. (2021) has established SS-31 as a well-characterized tool for researchers investigating mitochondrial bioenergetics, membrane biology, and oxidative stress in cell culture and preclinical model systems.
References
- Birk, A.V., et al. (2013). The mitochondrial-targeted compound SS-31 re-energizes ischemic mitochondria by interacting with cardiolipin. Journal of the American Society of Nephrology, 24(8), 1250-1261.
- Siegel, M.P., et al. (2021). Mitochondrial-targeted peptide SS-31 may modulate mitochondrial cristae remodeling. Aging Cell, 20(4), e13350.
- Szeto, H.H. (2014). First-in-class cardiolipin-protective compound as a research tool for mitochondrial bioenergetics. British Journal of Pharmacology, 171(8), 2029-2050.
- Zhao, K., et al. (2004). Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury. Journal of Biological Chemistry, 279(33), 34682-34690.
Disclaimer: All products sold by Aureum Peptides are intended for laboratory and research use only. Not for human consumption. SS-31 (Elamipretide) is sold as a research chemical. No statements on this page have been evaluated by the FDA. This product is not intended to diagnose, treat, supports research into, or may modulate any disease. For Research Use Only.
